Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-up

In Eastern Cooperative Oncology Group-ACRIN E4A03, on completion of four cycles of therapy, newly diagnosed multiple myeloma patients had the option of proceeding to autologous peripheral blood stem cell transplant (ASCT) or continuing on their assigned therapy lenalidomide plus low-dose dexamethaso...

Descripción completa

Detalles Bibliográficos
Autores principales: Biran, N, Jacobus, S, Vesole, D H, Callander, N S, Fonseca, R, Williams, M E, Abonour, R, Katz, M S, Rajkumar, S V, Greipp, P R, Siegel, D S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056965/
https://www.ncbi.nlm.nih.gov/pubmed/27588519
http://dx.doi.org/10.1038/bcj.2016.68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056965/
https://www.ncbi.nlm.nih.gov/pubmed/27588519
http://dx.doi.org/10.1038/bcj.2016.68

Ejemplares similares